CRENESSIFRIENDS

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Dec 2024 filing date already counts against anyone who files later.

Record

Serial number

98908360

Mark type

Stylized text

Filed

17 Dec 2024

Published for opposition

13 Jan 2026

Attorney of record

Allison Strickland Ricketts

Goods and services

• Class 009 — Scientific and electric apparatus: Downloadable children's books; downloadable children's booklets in the fields of health and pharmaceuticals; downloadable children's booklets in the fields of congenital adrenal hyperplasia, adrenal insufficiency and endocrine diseases and disorders; downloadable children's activity books; downloadable electronic newsletters in the fields of health and pharmaceuticals; downloadable electronic newsletters in the fields of congenital adrenal hyperplasia, adrenal insufficiency and endocrine diseases and disorders; downloadable computer software games
• Class 016 — Paper goods and printed matter: Printed children's books; printed children's booklets; printed children's activity books; printed newsletters in the field of endocrine diseases and disorders
• Class 035 — Advertising and business services: Promoting public awareness of congenital adrenal hyperplasia by means of discussion of congenital adrenal hyperplasia and coping strategies; Promoting public awareness of adrenal insufficiency by means of discussion of adrenal insufficiency and coping strategies; Promoting public awareness of endocrine diseases and disorders by means of discussion of endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders
• Class 036 — Insurance and financial services: Patient support services, namely, insurance consultation on access to medicines; Patient support services, namely, providing financial assistance for pharmaceutical co-pays; patient support services, namely, providing consultation and information on insurance coverage and reimbursement
• Class 038 — Telecommunications services: Providing an online forum in the field of health and pharmaceuticals
• Class 041 — Education and entertainment services: Educational services, namely, conducting classes, seminars, conferences, workshops, retreats, camps and field trips in the fields of health and pharmaceuticals and distribution of training material in connection therewith; Educational services, namely, conducting classes, seminars, conferences, workshops, retreats, camps and field trips in the fields of congenital adrenal hyperplasia, adrenal insufficiency and endocrine diseases and disorders; education services, namely, providing mentorship programs in the field of health and pharmaceuticals
• Class 042 — Scientific and technological services: Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders; creating an online community for users for the purpose of participating in discussions in the fields of health, pharmaceuticals, and coping strategies
• Class 044 — Medical, beauty and agricultural services: Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders; Patient support services, namely, providing medical information and consultation about available resources for patients, caregivers and healthcare providers; Providing medical information at in-person health forums for users participating in discussions in the field of congenital adrenal hyperplasia; Providing medical information at in-person health forums for users participating in discussions in the field of adrenal insufficiency; Providing medical information at in-person health forums for users participating in discussions in the field of endocrine diseases and disorders
• Class 045 — Legal and security services: Patient support services, namely, coordinating the procurement of medications; Patient support services, namely, providing emotional support for patients, caregivers and healthcare providers

Owner

• Neurocrine Biosciences, Inc., San Diego, CA, US
• Neurocrine Biosciences, Inc., San Diego, CA, US

Prosecution history

• 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 13 Jan 2026 — PUBLISHED FOR OPPOSITION
• 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 15 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 15 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
• 15 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 15 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
• 15 Dec 2025 — EXAMINERS AMENDMENT -WRITTEN
• 05 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 05 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 05 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 18 Jul 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 18 Jul 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 06 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED